Genetic basis of rifampicin resistance in methicillin-resistant Staphylococcus aureus suggests clonal expansion in hospitals in Cape Town, South Africa

BMC Microbiology

Volumn 12, Issue , 2012, Pages

  Jansen Van Rensburg, Melissa J ^a,d   Whitelaw, Andrew C ^a,b,c   Elisha, Brenda G ^a,b,c  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RIFAMPICIN; ANTIINFECTIVE AGENT; BACTERIAL DNA;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; AUSTRALIA; BACTERIAL GENE; BACTERIAL GENETICS; BACTERIAL MUTATION; BACTERIUM ISOLATE; CLONAL VARIATION; CONTROLLED STUDY; GENOTYPE; HOSPITAL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PREVALENCE; RPOB GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTH AFRICA; DRUG EFFECT; GENETICS; HUMAN; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MULTIDRUG RESISTANCE; STAPHYLOCOCCUS INFECTION;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; DNA MUTATIONAL ANALYSIS; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENOTYPE; HOSPITALS; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; POLYMORPHISM, SINGLE NUCLEOTIDE; RIFAMPIN; SOUTH AFRICA; STAPHYLOCOCCAL INFECTIONS;

EID: 84858736801     PISSN: None     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-12-46     Document Type: Article

References (26)

1. The 2000 Garrod Lecture. Factors impacting on the problem of antibiotic resistance. Levy SB, J Antimicrob Chemoth 2002 49 25 30 10.1093/jac/49.1.25 (Pubitemid 34100643)
2. Antimicrobial susceptibility of methicillin-resistant Staphylococcus aureus isolates from South Africa. Marais E, Aithma N, Perovic O, Oosthuysen WF, Musenge E, Dusé AG, SAMJ 2009 99 170 173 19563094
3. Antimicrobial susceptibility patterns and characterization of clinical isolates of Staphylococcus aureus in KwaZulu-Natal province, South Africa. Shittu AO, Lin J, BMC Infect Dis 2006 6 125 10.1186/1471-2334-6-125 16875502 (Pubitemid 44390025)
4. Staphylococcus aureus bacteraemia on admission in paediatric patients at Chris Hani Baragwanath Hospital, Soweto. Groome MJ, Albrich W, Khoosal M, Wadula J, Madhi SA, Abstracts: 3rd FIDSSA Congress, 2009: 20-23 August 2009; South Africa 2009 26 27
5. The dominant methicillin-resistant Staphylococcus aureus clone from hospitals in Cape Town has an unusual genotype: ST612. Jansen van Rensburg MJ, Madikane VE, Whitelaw A, Chachage M, Haffejee S, Elisha BG, Clin Microbiol Infect 2011 17 785 792 10.1111/j.1469-0691.2010.03373.x 20854426
6. Molecular characterization of clinical methicillin-resistant Staphylococcus aureus in South Africa. Moodley A, Oosthuysen WF, Dusé AG, Marais E, the South African MRSA Surveillance Group, J Clin Microbiol 2010 48 4608 4611 10.1128/JCM.01704-10 20881169
7. The Multilocus Sequence Typing Network. http://saureus.mlst.net/
8. Molecular epidemiology of methicillin-resistant and methicillin- susceptible Staphylococcus aureus isolates from global clinical trials. Goering RV, Shawar RM, Scangarella NE, O'Hara FP, Amrine-Madsen H, West JM, Dalessandro M, Becker JA, Walsh SL, Miller LA, van Horn SF, Thomas ES, Twynholm ME, J Clin Microbiol 2008 46 2842 2847 10.1128/JCM.00521-08 18614654
9. Evolution and diversity of community-associated methicillin-resistant Staphylococcus aureus in a geographical region. Coombs G, Monecke S, Pearson JC, Tan H, Chew Y, Wilson L, Ehricht R, O'Brien FG, Christiansen KJ, BMC Microbiol 2011 11 215 10.1186/1471-2180-11-215 21955438
10. Structural Mechanism for Rifampicin Inhibition of Bacterial RNA Polymerase. Campbell EA, Korzheva N, Mustaev A, Murakami K, Nair S, Goldfarb A, Darst SA, Cell 2001 104 901 912 10.1016/S0092-8674(01)00286-0 11290327 (Pubitemid 32289282)
11. Characterization of mutations in the rpoB gene that confer rifampin resistance in Staphylococcus aureus. Aubry-Damon H, Soussy CJ, Courvalin P, Antimicrob Agents Chemother 1998 42 2590 2594 9756760 (Pubitemid 28462898)
12. Molecular characterization of rpoB mutations conferring cross-resistance to rifamycins on methicillin-resistant Staphylococcus aureus. Wichelhaus TA, Schafer V, Brade V, Böddinghaus B, Antimicrob Agents Chemother 1999 43 2813 2816 10543773 (Pubitemid 29519574)
13. Molecular genetic and structural modeling studies of Staphylococcus aureus RNA polymerase and the fitness of rifampin resistance genotypes in relation to clinical prevalence. O'Neill AJ, Huovinen T, Fishwick CWG, Chopra I, Antimicrob Agents Chemother 2006 50 298 309 10.1128/AAC.50.1.298-309.2006 16377701 (Pubitemid 43042936)
14. Emergence of rifampicin resistance in methicillin-resistant Staphylococcus aureus in tuberculosis wards. Sekiguchi J, Fujino T, Araake M, Toyota E, Kudo K, Saruta K, Yoshikura H, Kuratsuji T, Kirikae T, J Infect Chemother 2006 12 47 50 10.1007/s10156-005-0417-8 16506090
15. Molecular characterization of resistance to rifampicin in an emerging hospital-associated methicillin-resistant Staphylococcus aureus clone ST228, Spain. Mick V, Domínguez MA, Tubau F, Lĩares J, Pujol M, Martin R, BMC Microbiol 2010 10 68 10.1186/1471-2180-10-68 20202188
16. Epidemiological and molecular aspects of rifampicin-resistant Staphylococcus aureus isolated from wounds, blood and respiratory samples. Villar M, Marimán JM, García-Arenzana JM, de la Campa AG, Ferrándiz MJ, Pérez-Trallero E, J Antimicrob Chemother 2011 66 997 1000 10.1093/jac/dkr059 21393177
17. Impact of rpoB mutations on reduced vancomycin susceptibility in Staphylococcus aureus. Watanabe Y, Cui L, Katayama Y, Kozue K, Hiramatsu K, J Clin Microbiol 2011 49 2680 2684 10.1128/JCM.02144-10 21525224
18. VassarStats: Website for Statistical Computation. http://vassarstats.net/
19. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Hall TA, Nucl Acids Symp Ser 1999 41 95 98
20. Codon Usage Database. http://www.kazusa.or.jp/codon/
21. Synonymous codon usage in bacteria. Ermolaeva MD, Curr Issues Mol Biol 2001 3 91 97 11719972 (Pubitemid 33061772)
22. General rules for optimal codon choice. Hershberg R, Petrov DA, PLoS Genet 2009 5 7 1000556 10.1371/journal.pgen.1000556 19593368
23. Methicillin-resistant Staphylococcus aureus in a population of horses in Australia. Axon JE, Carrick JB, Barton MD, Collins NM, Russell CM, Kiehnea J, Coombs G, Aust Vet J 2011 89 221 225 10.1111/j.1751-0813.2011.00711.x 21595643
24. Compensatory evolution in rifampin-resistant Escherichia coli. Reynolds MG, Genetics 2000 156 1471 1481 11102350 (Pubitemid 32001218)
25. The biological cost of mutational antibiotic resistance: any practical conclusions? Andersson DI, Curr Opin Microbiol 2006 9 461 465 10.1016/j.mib.2006.07.002 16890008 (Pubitemid 44397630)
26. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. Soriano A, Marco F, Martínez JA, Pisos E, Almela M, Dimova VP, Alamo D, Ortega M, Lopez J, Mensa J, Clin Infect Dis 2008 46 193 200 10.1086/524667 18171250 (Pubitemid 351269157)